Propiconazole (CASRN 60207-90-1)
view QuickView

0282
Propiconazole;
CASRN 60207-90-1
Health assessment information on a chemical substance is included in IRIS
only after a comprehensive review of chronic toxicity data by U.S. EPA
health scientists from several Program Offices and the Office of Research
and Development. The summaries presented in Sections I and II represent
a consensus reached in the review process. Background information and
explanations of the methods used to derive the values given in IRIS are
provided in the Background Documents.
STATUS OF DATA FOR Propiconazole
File First On-Line 06/30/1988
Category (section) |
Status |
Last Revised |
---|---|---|
Oral RfD Assessment (I.A.) | on-line | 01/01/1992 |
Inhalation RfC Assessment (I.B.) | no data | |
Carcinogenicity Assessment (II.) | no data |
_I. Chronic Health Hazard Assessments for Noncarcinogenic Effects
_I.A. Reference Dose for Chronic Oral Exposure (RfD)
Substance Name — Propiconazole
CASRN — 60207-90-1
Primary Synonym — Banner
Last Revised — 01/01/1992
The oral Reference Dose (RfD) is based on the assumption that thresholds
exist for certain toxic effects such as cellular necrosis. It is expressed
in units of mg/kg-day. In general, the RfD is an estimate (with uncertainty
spanning perhaps an order of magnitude) of a daily exposure to the human
population (including sensitive subgroups) that is likely to be without
an appreciable risk of deleterious effects during a lifetime. Please refer
to the Background Document for an elaboration of these concepts. RfDs
can also be derived for the noncarcinogenic health effects of substances
that are also carcinogens. Therefore, it is essential to refer to other
sources of information concerning the carcinogenicity of this substance.
If the U.S. EPA has evaluated this substance for potential human carcinogenicity,
a summary of that evaluation will be contained in Section II of this file.
__I.A.1. Oral RfD Summary
Critical Effect |
Experimental Doses* |
UF |
MF |
RfD |
---|---|---|---|---|
Gastric mucosal 1-Year Dog Ciba Geigy, 1985a |
NOEL: 50 ppm (1.25 LEL: 250 ppm (6.25 |
100
|
1
|
1.3E-2
mg/kg/day |
*Conversion Factors and Assumptions — 1 ppm = 0.025 mg/kg/day (assumed dog food consumption)
__I.A.2. Principal and Supporting Studies (Oral RfD)
Ciba Geigy Corporation. 1985a. MRID No. 00151515, 93194036. Available from EPA. Write to FOI, EPA, Washington, DC 20460.
Beagle dogs (5 to 7/sex/group) were fed diets containing propiconazole technical material at levels of 0, 5, 50, or 250 ppm (0, 0.125, 1.25, 6.25 mg/kg/day) for 12 months. No dose-related effects were found on mortality, organ or body weights, food consumption, or clinical laboratory parameters. Necropsy and histopathologic examinations revealed evidence of mild irritation of the stomach in males given the highest dietary concentration (250 ppm).
__I.A.3. Uncertainty and Modifying Factors (Oral RfD)
UF — An uncertainty factor of 100 was used to account for the inter- and intraspecies differences.
MF — None
__I.A.4. Additional Studies/Comments (Oral RfD)
Data Considered for Establishing the RfD
1) 1-Year Feeding - dog: Principal study - see previous description; core grade minimum
2) 2-Year Feeding (oncogenic) - rat: Systemic NOEL=100 ppm (5 mg/kg/day); Systemic LEL=500 ppm (25 mg/kg/day) (hepatotoxicity in males and exocrine atrophy of pancreas in females); core grade minimum (Ciba Geigy, 1982a)
3) 2-Generation Reproduction - rat: Parental NOEL=none; LEL=100 ppm (5 mg/kg/day) (LDT; hepatic clear-cell change); Reproductive NOEL=2500 ppm (125 mg/kg/day) (HDT); Developmental NOEL=500 ppm (25 mg/kg/day); Developmental LEL=2500 ppm (125 mg/kg/day) (reduced survival, reduced body weight, increased hepatocellular swelling); core grade minimum (Ciba Geigy, 1985b
4) Teratology - rat: Teratogenic NOEL=300 mg/kg/day (HDT); Fetal NOEL=30 mg/kg/day; Fetal LEL=100 mg/kg/day (ossification retardation); Maternal NOEL=100 mg/kg/day; Maternal LEL=300 mg/kg/day (decreased body weight gain and food consumption); core grade minimum (Ciba Geigy, 1979a)
5) Teratology - rabbit: Maternal, Fetal, and Teratogenic NOEL=180 mg/kg/day (HDT); core grade minimum (Ciba Geigy, 1979b)
Other Data Reviewed:
1) 2-Year Feeding (oncogenic) - mouse: Systemic NOEL=100 ppm (15 mg/kg/day); Systemic LEL=500 ppm (75 mg/kg/day) (decreased body weight gain, hepatotoxicity); core grade minimum (Ciba Geigy, 1982b)
2) 90-Day Feeding - dog: Systemic NOEL=50 ppm (1.25 mg/kg/day); Systemic LEL=250 ppm (6.25 mg/kg/day) (inflammation of gastric mucosa); core grade minimum (Ciba Geigy, 1979c)
3) 90-Day Feeding - rat: Systemic NOEL=240 ppm (12 mg/kg/day); Systemic LEL=1200 ppm (60 mg/kg/day) (reduced body weight gain); core grade minimum (Ciba Geigy, 1979d)
Data Gap(s): None
__I.A.5. Confidence in the Oral RfD
Study — Medium
Database — High
RfD — High
The critical study is of adequate quality and is given a medium confidence rating. The database on chronic exposure toxicity if also of adequate quality and the findings of a 3-month subchronic dog study correlate well with those of the critical study; therefore, the database is given a high confidence rating. High confidence in the RfD follows.
__I.A.6. EPA Documentation and Review of the Oral RfD
Source Document — This assessment is not presented in any existing U.S. EPA document.
Other EPA Documentation — Pesticide Registration Files
Agency Work Group Review — 07/15/1987, 05/25/1988
Verification Date — 05/25/1988
Screening-Level Literature Review Findings — A screening-level review conducted by an EPA contractor of the more recent toxicology literature pertinent to the RfD for propiconazole conducted in August 2003 did not identify any critical new studies. IRIS users who know of important new studies may provide that information to the IRIS Hotline at hotline.iris@epa.gov or 202-566-1676.
__I.A.7. EPA Contacts (Oral RfD)
Please contact the IRIS Hotline for all questions concerning this assessment or IRIS, in general, at (202)566-1676 (phone), (202)566-1749 (FAX) or hotline.iris@epa.gov (internet address).
_I.B. Reference Concentration for Chronic Inhalation Exposure (RfC)
Substance Name — Propiconazole
CASRN — 60207-90-1
Primary Synonym — Banner
Not available at this time.
_II. Carcinogenicity Assessment for Lifetime Exposure
Substance Name — Propiconazole
CASRN — 60207-90-1
Primary Synonym — Banner
Not available at this time.
_III.
[reserved]
_IV. [reserved]
_V. [reserved]
_VI. Bibliography
Substance Name — Propiconazole
CASRN — 60207-90-1
Primary Synonym — Banner
Last Revised — 01/01/1992
_VI.A. Oral RfD References
Ciba Geigy Corporation. 1979a. MRID No. 00058604, 00143454. Available from EPA. Write to FOI, EPA, Washington, DC 20460.
Ciba Geigy Corporation. 1979b. MRID No. 00058605, 00143454. Available from EPA. Write to FOI, EPA, Washington, DC 20460.
Ciba Geigy Corporation. 1979c. MRID No. 00058607, 93194032, 93194084. Available from EPA. Write to FOI, EPA, Washington, DC 20460.
Ciba Geigy Corporation. 1979d. MRID No. 00058606, 93194033, 93194083. Available from EPA. Write to FOI, EPA, Washington, DC 20460.
Ciba Geigy Corporation. 1982a. MRID No. 00074494, 00129918, 00151502, 93194035. Available from EPA. Write to FOI, EPA, Washington, DC 20460.
Ciba Geigy Corporation. 1982b. MRID No. 00129570, 00084153, 00130844, 00151503, 93194037. Available from EPA. Write to FOI, EPA, Washington, DC 20460.
Ciba Geigy Corporation. 1985a. MRID No. 00151515, 93194036. Available from EPA. Write to FOI, EPA, Washington, DC 20460.
Ciba Geigy Corporation. 1985b. MRID No. 00138167, 00151514, 00163164. Available from EPA. Write to FOI, EPA, Washington, DC 20460.
_VI.B. Inhalation RfD References
None
_VI.C. Carcinogenicity Assessment References
None
_VII. Revision History
Substance Name — Propiconazole
CASRN — 60207-90-1
Primary Synonym — Banner
Date |
Section |
Description |
---|---|---|
08/22/1988 | I.A.1. | Dose conversion factor changed; RfD changed |
08/22/1988 | I.A.2. | Dose levels changed; reflects altered conversion factor |
02/01/1991 | II. | Carcinogen assessment now under review |
01/01/1992 | I.A.4. | Citations added |
01/01/1992 | VI. | Bibliography on-line |
08/01/1995 | II. | EPA's RfD/RfC and CRAVE workgroups were discontinued in May, 1995. Chemical substance reviews that were not completed by September 1995 were taken out of IRIS review. The IRIS Pilot Program replaced the workgroup functions beginning in September, 1995. |
04/01/1997 | III., IV., V. | Drinking Water Health Advisories, EPA Regulatory Actions, and Supplementary Data were removed from IRIS on or before April 1997. IRIS users were directed to the appropriate EPA Program Offices for this information. |
10/28/2003 | I.A.6 | Screening-Level Literature Review Findings message has been added. |
_VIII. Synonyms
Substance Name — Propiconazole
CASRN — 60207-90-1
Primary Synonym — Banner
Last Revised — 06/30/1988
- 60207-90-1
- Banner
- CGA-64250
- CGD 92710F
- DESMEL
- 1-(2-(2,4-DICHLOROPHENYL)-4-PROPYL-1,3-DIOXOLAN-2-YLMETHYL)-1H-1,2,4-TRIAZOLE PROCONAZOLE
- Propiconazole
- RADAR
- TILT
- 1H-1,2,4-TRIAZOLE, 1-((2-(2,4-DICHLOROPHENYL)-4-PROPYL-1,3-DIOXOLAN-2-YL) METHYL)-